BioCentury
ARTICLE | Company News

Biovail receives FDA approval

September 28, 2000 7:00 AM UTC

The FDA granted final marketing approval for BVF's generic version of Procardia XL nifedipine, which is marketed by Pfizer (PFE, New York, N.Y.) to treat hypertension and angina. Partner Teva (TEVA) w...